Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs.
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000605:Amino Alcohols / Q000627:therapeutic use*; D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D004195:Disease Models, Animal; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D007545:Isoproterenol; D008026:Ligation; D008566:Membranes / Q000187:drug effects; D011433:Propranolol / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy*; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D011433:Propranolol; D013015:Sotalol; D007545:Isoproterenol